Plain-English translation of NCT07194200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a naturally occurring beneficial bacteria, as a treatment for psoriasis. Researchers believe that psoriasis may be linked to an imbalance in the bacteria living on the skin, and this medication aims to restore that healthy balance. Half of participants will receive the active treatment, and half will receive an inactive version to compare results.
Current psoriasis treatments help many people, but researchers have found that the condition may be connected to an unhealthy balance of bacteria on the skin. This trial is exploring whether this new treatment could offer a gentler, microbiome-based approach to managing psoriasis.
You likely qualify if…
You likely don't qualify if…
If you join, you'll apply 5 milliliters of the treatment solution directly to your psoriasis patches every day for 2 months. You'll be randomly assigned to receive either the active beneficial bacteria treatment or an inactive version (placebo), and neither you nor the researchers will know which one you're getting during the study. You'll need to be available for assessments to measure how well the treatment is working.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China